Johnson & Johnson files application to conduct a study of its COVID-19 vaccine in India in adolescents aged 12 – 17 years

Johnson & Johnson files application to conduct a study of its COVID-19 vaccine in India in adolescents aged 12 – 17 years

On behalf of a Johnson & Johnson India spokesperson:

Johnson & Johnson is committed to facilitating global equitable access to its COVID-19 vaccine and recognize the unmet needs of children. On 17 August, 2021, we submitted an application to the Central Drugs Standard Control Organisation (CDSCO) to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged 12 – 17 years.

To ultimately achieve herd immunity, it is imperative that COVID-19 vaccine clinical trials continue to move forward in this population, and we remain deeply committed to the critical work needed to make our COVID-19 vaccine equitably accessible for all age groups.